EarningsQ4 2024 Earnings Report

BeOne Medicines (ONCN) Q4 2024 Earnings Report

0 Followers

MX:ONCN Q4 2024 EPS Results

Actual EPS-$26.33

Consensus EPS-$18.64

Beat/MissMissed by -$7.70

One Year Ago EPS-$65.00

Actual Revenue$20.69B

Expected Revenue$19.24B

Beat/MissBeat by +$1.45B

YoY Revenue Growth+75.90%

QuarterQ4 2024

Date02/27/2025

TimeBefore Open

Conference CallThursday, February 27, 2025

MX:ONCN Upcoming Earnings

BeOne Medicines's next earnings date is estimated for October 31, 2026, based on past reporting schedules.

MX:ONCN Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 31, 2026	2026 (Q3)	34.73 / -	20.071	―
Aug 05, 2026	2026 (Q2)	30.59 / 37.75	16.757	125.27% (+20.99)
May 06, 2026	2026 (Q1)	17.82 / 36.09	0	―
Feb 26, 2026	2025 (Q4)	22.91 / 11.05	-26.332	141.96% (+37.38)
Nov 06, 2025	2025 (Q3)	15.67 / 20.07	-21.176	194.78% (+41.25)
Aug 06, 2025	2025 (Q2)	7.13 / 16.76	-21.176	179.13% (+37.93)
May 07, 2025	2025 (Q1)	-10.57 / 0.00	-44.378	―
Feb 27, 2025	2024 (Q4)	-18.64 / -26.33	-65.002	59.49% (+38.67)
Nov 12, 2024	2024 (Q3)	-20.51 / -21.18	37.012	-157.21% (-58.19)
Aug 26, 2024	2024 (Q2)	-40.31 / -21.18	-67.028	68.41% (+45.85)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed